Lv1
58 积分 2025-03-21 加入
Selective PARP1 inhibitors (2021-2025): patent landscape, structural evolution, and future therapeutic opportunities
8小时前
已完结
An algorithmic framework for synthetic cost-aware decision making in molecular design
3个月前
已完结
Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action
4个月前
已完结
Structural basis for allosteric PARP-1 retention on DNA breaks
4个月前
已完结
Machine learning-aided generative molecular design
4个月前
已完结
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
6个月前
已完结
Predicting adverse drug reactions for combination pharmacotherapy with cross-scale associative learning via attention modules
7个月前
已完结
SynGFN: learning across chemical space with generative flow-based molecular discovery
9个月前
已完结
Real-world validation of a structure-aware pipeline for molecular design
9个月前
已完结
OptADMET: a web-based tool for substructure modifications to improve ADMET properties of lead compounds
10个月前
已完结
皖公网安备34019202002308
